Evidence for the presence of dopamine D1 receptor mRNA and binding sites in monkey amniotic epithelial cells

Neuroscience Letters

Volumn 262, Issue 1, 1999, Pages 9-12

  Elwan, Mohamed A ^a   Ishii, Takashi ^a   Ono, Fumiko ^b   Sakuragawa, Norio ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Tsukuba ^*  (Japan)

Author keywords

3 H SCH 23390; Amniotic epithelial cells; D1 mRNA; Dopamine D1 receptors; RT PCR

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; MESSENGER RNA; RADIOLIGAND;

AMNION CELL; ANIMAL CELL; BINDING SITE; CONTROLLED STUDY; DOPAMINE METABOLISM; EPITHELIUM CELL; FEMALE; LIGAND BINDING; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE HOMOLOGY;

EID: 0033605206     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00016-6     Document Type: Article

References (20)

1. Alexander G.M., Schwatzman R.J., Grothusen J.R., Brainard L., Gordon S.W. Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment. Brain Res. 625:1993;276-282.
2. 3H]SCH 23390 binding in rat striatum. Life Sci. 37:1985;1971-1983.
3. 1 receptor antagonist ligand, in rat striatum. Life Sci. 35:1984;1885-1893.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
5. 2L receptor cDNAs. Mol. Brain Res. 36:1996;292-299.
6. 1 dopamine receptor. Nature. 347:1990;72-76.
7. 2 dopamine receptor. Biochemistry. 34:1995;13635-13641.
8. 1 dopamine receptors following chronic administration of SCH 39166 in primates. Pharmacol. Biochem. Behav. 41:1991;235-238.
9. Elwan M.A., Thangavel R., Ono F., Sakuragawa N. Synthesis and release of catecholamines by cultured monkey amniotic cells. J. Neurosci. Res. 53:1998;107-113.
10. Filtz T.M., Artymyshyn R.P., Guan W., Molinoff P.B. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol. Pharmacol. 44:1993;371-379.
11. Hall H., Frade L., Sedvall G. Human dopamine receptor subtypes: in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. J. Neural. Transm. 73:1988;7-21.
12. Jackson D.M., Weslind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioral aspects. Pharmacol. Ther. 64:1994;291-370.
13. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-96.
14. Lévesque D., Diaz J., Pilon C., Martres M.-P., Giros B., Souil E., Schott D., Morgat J.-L., Schwartz J.-C., Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA. 89:1992;8155-8159.
15. 1 dopamine receptor gene. Mol. Pharmacol. 41:1992;652-659.
16. 2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). J. Neurochem. 51:1988;934-943.
17. O'Boyle K.M., Waddington J.L. [3H]SCH 23390 binding to human putamen D-1 dopamine receptors: stereochemical and structure-affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to D-1 receptor topography. J. Neurochem. 48:1987;1039-1042.
18. 1 receptors in the putamen of control and parkinsonian subjects. Eur. J. Pharmacol. 113:1985;467-468.
19. 2 receptor. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 225:1992;331-337.
20. 2 receptors expressed in different cell types. J. Biol. Chem. 265:1990;10320-10326.